Noah Scherrer, MD
Vascular Surgery · Louisville, KYNPI 1740423896
Payments from drug & device makers
What this record shows
W. L. Gore & Associates, Inc. accounts for 66.0% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $2,907 and has fallen 61.0% since, to $1,135 in 2025. That places this record below the midpoint for vascular surgery clinicians in KY, where the typical reported total is $9,151.
Across 115 payments — averaging $66.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$5K
- Boston Scientific$960
- Terumo Medical Corporation$240
- Sanara Medtech Inc.$198
- Endologix LLC$171
- Bolton Medical Inc$155
- plus $862 from 21 others
What the payments were for
- Travel & lodging$3,61548%
- Food & beverage$3,98452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 28 | $5,014 |
| Boston Scientific | 44 | $960 |
| Terumo Medical Corporation | 4 | $240 |
| Sanara Medtech Inc. | 4 | $198 |
| Endologix LLC | 1 | $171 |
| Bolton Medical Inc | 1 | $155 |
| Silk Road Medical, Inc. | 1 | $131 |
| Lemaitre Vascular, Inc. | 2 | $103 |
| Medtronic(2 entities) | 2 | $92 |
| Bone Support Inc. | 2 | $89 |
| Inari Medical, Inc. | 3 | $81 |
| E.r. Squibb & Sons, L.L.C. | 4 | $53 |
| Stryker | 2 | $44 |
| Cook Medical LLC | 2 | $32 |
| Bard Peripheral Vascular, Inc. | 2 | $32 |
| EKOS Corporation | 2 | $27 |
| Baxter Healthcare | 1 | $26 |
| Angiodynamics, Inc. | 1 | $24 |
| Pfizer | 1 | $17 |
| Atricure, Inc. | 1 | $16 |
| Argon Medical Devices, Inc. | 1 | $16 |
| Polynovo North America LLC | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Surmodics, Inc. | 1 | $12 |
| Philips North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Thoracic Endoprosthesis$2,333
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$2,071
- GENERAL VASCULAR INTERVENTION$257
- Torus Stent Graft System$171
- ENDOCROSS Device$171
- TREO ABDOMINAL STENT-GRAFT SYSTEM$155
- CellerateRx$142
- GORE VIABAHN VBX Balloon Expandable Endo$138
- ENROUTE Transcarotid Stent$131
- ENROUTE Transcarotid Neuroprotection System$131
- GORE EXCLUDER AAA Endoprosthesis$121
How this compares
$7,599 in reported general payments places this provider in the 40th percentile of 72 vascular surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $58,799 |
| XareltoRivaroxaban | 19 | $18,108 |
| Cilostazol | 92 | $1,368 |
| ClopidogrelClopidogrel Bisulfate | 154 | $1,079 |
| Atorvastatin Calcium | 99 | $526 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $140 |
| Pravastatin Sodium | 19 | $101 |
| Oxycodone Hcl | 18 | $50 |
| Pantoprazole Sodium | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $58,79988 claims |
| Johnson & JohnsonXarelto | $13 | $18,10819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 72 vascular surgery providers in Kentucky.
Other vascular surgery in Louisville
- Amit DwivediLouisville$406K
- Abindra SigdelLouisville$84K
- Ferenc NagyLouisville$47K
- Gregory SchmiederLouisville$44K
- Erik WayneLouisville$25K
- Matthew JungLouisville$24K
- Nancy ClarkLouisville$19K
- Ashlee VinyardLouisville$12K
- Salem GeorgeLouisville$10K
- Nathaniel LiuLouisville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.